These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 5515661)
41. [Movement disorders as a concomitant syndrome in the use of psychopharmacological agents]. von der Mühlen H Z Allgemeinmed; 1973 Oct; 49(30):1441-7. PubMed ID: 4768492 [No Abstract] [Full Text] [Related]
42. [Clinical study of amantadine in extrapyramidal syndromes caused by neuroleptics]. Nardini M; Fanali A; Sorgonà F; Vergnano M; Fieschi G Minerva Med; 1971 Oct; 62(82):4020-3. PubMed ID: 5125070 [No Abstract] [Full Text] [Related]
44. Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature. Crane GE Am J Psychiatry; 1968 Feb; 124(8):Suppl:40-8. PubMed ID: 4865731 [No Abstract] [Full Text] [Related]
45. [Correlation between antipsychotic and extrapyramidal properties of neuroleptics]. Filotto J; Bordeleau JM; Tétreault L Union Med Can; 1969 Apr; 98(4):562-6. PubMed ID: 5355787 [No Abstract] [Full Text] [Related]
46. [Depression syndrome in the course of neuroleptic therapy]. Helmchen H; Hippius H Nervenarzt; 1967 Oct; 38(10):455-8. PubMed ID: 6052776 [No Abstract] [Full Text] [Related]
47. A Nigerian psychiatric outpatient clinic: a point prevalence study. Odejide AO J Clin Psychiatry; 1980 Apr; 41(4):130-3. PubMed ID: 6102561 [TBL] [Abstract][Full Text] [Related]
48. [Evaluation in clinical trials of some drug associations. (L-dopa, neuroleptics and lithium carbonate)]. Longo V; Kemali D; Pacini A; Bertolino A; Lamura G Boll Soc Ital Biol Sper; 1971 Aug; 47(15):470-2. PubMed ID: 5158530 [No Abstract] [Full Text] [Related]
49. [Chronic facio-lingual dyskinesia in patients treated with neuroleptics]. Gralewski Z Neurol Neurochir Pol; 1973; 7(3):393-8. PubMed ID: 4714195 [No Abstract] [Full Text] [Related]
50. [Tardive dyskinesia caused by neuroleptics. Survey of 3,140 psychiatric hospital patients]. Bourgeois M; Tignol J Nouv Presse Med; 1977 Nov; 6(39):3649-50. PubMed ID: 607184 [No Abstract] [Full Text] [Related]
52. [Catatonia and extrapyramidal syndrome]. Ostaptzeff ; Ostaptzeff-Lavoine Ann Med Psychol (Paris); 1970 Jul; 2(2):256-61. PubMed ID: 5475411 [No Abstract] [Full Text] [Related]
53. [Hyperthermias due to neuroleptics. Attempted physiopathological interpretation]. Aubert C Encephale; 1973; 62(2):126-59. PubMed ID: 4356486 [No Abstract] [Full Text] [Related]
54. [Tranquilizing agents: extrapyramidal and antiparkinsonism activities]. Bordeleau JM; Tétreault L; Elie R Vie Med Can Fr; 1972 Feb; 1(2):118-26. PubMed ID: 4637390 [No Abstract] [Full Text] [Related]
55. [On the question of possible irreversible disorders due to psychopharmacotherapy]. Meyer HH Arch Psychiatr Nervenkr (1970); 1966; 208(4):345-59. PubMed ID: 5969585 [No Abstract] [Full Text] [Related]
56. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients. Tanghe A; Vereecken JL Psychiatr Neurol Neurochir; 1971; 74(5):379-89. PubMed ID: 5138128 [No Abstract] [Full Text] [Related]
57. [On the problem of the therapeutical axis symptom of neuroleptic medicaments]. Glatzel J Psychiatr Neurol Med Psychol (Leipz); 1968 Aug; 20(8):286-95. PubMed ID: 5731884 [No Abstract] [Full Text] [Related]